Xiaode Feng

1.2k total citations
17 papers, 851 citations indexed

About

Xiaode Feng is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Xiaode Feng has authored 17 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Surgery and 6 papers in Cancer Research. Recurrent topics in Xiaode Feng's work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Xiaode Feng is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Xiaode Feng collaborates with scholars based in China, Madagascar and United States. Xiaode Feng's co-authors include Jian Wu, Shusen Zheng, Yunhao Chen, Junru Chen, Yuejie Lu, Beng Yang, Haiyang Xie, Qiyang Cheng, Rongliang Tong and Wenxuan Wu and has published in prestigious journals such as Hepatology, Oncogene and Small.

In The Last Decade

Xiaode Feng

17 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaode Feng China 12 642 478 114 104 67 17 851
Wen Peng China 14 588 0.9× 353 0.7× 94 0.8× 152 1.5× 103 1.5× 55 881
Xueliang Zuo China 17 892 1.4× 728 1.5× 65 0.6× 132 1.3× 34 0.5× 28 1.1k
Yingchen Xu China 16 475 0.7× 322 0.7× 81 0.7× 144 1.4× 87 1.3× 44 797
Yongxin Zhou China 12 801 1.2× 552 1.2× 81 0.7× 124 1.2× 34 0.5× 23 975
Jieyi Ma China 20 1.1k 1.7× 656 1.4× 117 1.0× 171 1.6× 68 1.0× 37 1.3k
Yuejie Lu China 9 545 0.8× 428 0.9× 104 0.9× 71 0.7× 38 0.6× 15 678
Yongchun Yu China 12 515 0.8× 387 0.8× 140 1.2× 86 0.8× 18 0.3× 18 721
Leping Yang China 17 398 0.6× 229 0.5× 108 0.9× 195 1.9× 117 1.7× 41 725
Yanting Shi China 11 563 0.9× 452 0.9× 95 0.8× 63 0.6× 53 0.8× 34 761
Tae‐Su Han South Korea 14 520 0.8× 383 0.8× 88 0.8× 110 1.1× 60 0.9× 24 718

Countries citing papers authored by Xiaode Feng

Since Specialization
Citations

This map shows the geographic impact of Xiaode Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaode Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaode Feng more than expected).

Fields of papers citing papers by Xiaode Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaode Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaode Feng. The network helps show where Xiaode Feng may publish in the future.

Co-authorship network of co-authors of Xiaode Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaode Feng. A scholar is included among the top collaborators of Xiaode Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaode Feng. Xiaode Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Tong, Rongliang, Xiaode Feng, Zhenan Ling, et al.. (2023). Co‐Delivery of siNRF2 and Sorafenib by a “Click” Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma. Small. 20(21). e2307273–e2307273. 17 indexed citations
2.
Wu, Wenxuan, Qiyang Cheng, Junru Chen, et al.. (2021). Left-side vs. right-side hepatectomy for hilar cholangiocarcinoma: a meta-analysis. World Journal of Surgical Oncology. 19(1). 107–107. 8 indexed citations
3.
Xu, Xiaofeng, Diyu Chen, Xiaode Feng, et al.. (2021). Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma. Frontiers in Oncology. 11. 654689–654689. 4 indexed citations
4.
Cai, Xianlei, Yunhao Chen, Da Man, et al.. (2021). RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner. Cell Death Discovery. 7(1). 315–315. 59 indexed citations
5.
6.
Chen, Yunhao, Yanchun Zhao, Junru Chen, et al.. (2020). ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1. Molecular Cancer. 19(1). 123–123. 205 indexed citations
7.
Chen, Junru, Chaofeng Ding, Yunhao Chen, et al.. (2020). ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway. Cancer Letters. 502. 154–165. 162 indexed citations
8.
9.
Chen, Xuerui, Rongliang Tong, Bingbing Liu, et al.. (2019). Duo of (–)-epigallocatechin-3-gallate and doxorubicin loaded by polydopamine coating ZIF-8 in the regulation of autophagy for chemo-photothermal synergistic therapy. Biomaterials Science. 8(5). 1380–1393. 46 indexed citations
10.
Chen, Diyu, Hao Wu, Bin He, et al.. (2019). <p>Five Hub Genes Can Be The Potential DNA Methylation Biomarkers For Cholangiocarcinoma Using Bioinformatics Analysis</p>. OncoTargets and Therapy. Volume 12. 8355–8365. 10 indexed citations
11.
Wu, Jingbang, Beng Yang, Yanpeng Zhang, et al.. (2019). miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5. International Journal of Biological Sciences. 15(8). 1591–1599. 54 indexed citations
12.
Chen, Diyu, Linping Cao, Xiaode Feng, et al.. (2019). Spontaneous rupture of solid pseudopapillary tumor of pancreas. Medicine. 98(44). e17554–e17554. 11 indexed citations
13.
Chen, Diyu, Xiaode Feng, Zhen Lv, et al.. (2019). ACADS acts as a potential methylation biomarker associated with the proliferation and metastasis of hepatocellular carcinomas. Aging. 11(20). 8825–8844. 26 indexed citations
14.
Yang, Beng, Hua Liu, Yang Huang, et al.. (2019). Combinatorial photochemotherapy on liver cancer stem cells with organoplatinum(ii) metallacage-based nanoparticles. Journal of Materials Chemistry B. 7(42). 6476–6487. 28 indexed citations
15.
Liu, Hua, Xiaode Feng, Beng Yang, et al.. (2019). Dimethyl fumarate suppresses hepatocellular carcinoma progression via activating SOCS3/JAK1/STAT3 signaling pathway.. PubMed. 11(8). 4713–4725. 16 indexed citations
16.
Chen, Diyu, et al.. (2018). Cystic lymphangioma of pancreas. Medicine. 97(28). e11238–e11238. 2 indexed citations
17.
He, Bin, Longfei Dai, Xiaoqian Zhang, et al.. (2018). The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction. International Journal of Biological Sciences. 14(13). 1845–1858. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen Peng Breakdown of academic impact, for papers by Xueliang Zuo Breakdown of academic impact, for papers by Yingchen Xu Breakdown of academic impact, for papers by Yongxin Zhou Breakdown of academic impact, for papers by Jieyi Ma Breakdown of academic impact, for papers by Yuejie Lu Breakdown of academic impact, for papers by Yongchun Yu Breakdown of academic impact, for papers by Leping Yang Breakdown of academic impact, for papers by Yanting Shi Breakdown of academic impact, for papers by Tae‐Su Han
Rankless by CCL
2026